Historical record - last NADAC publication: 11/18/2020
Product Information
QC ACETAMINOPHEN 8-HR 650 MG is a generic product labeled by Chain Drug Marketing Association, priced at $0.0606 per EA under NDC 63868009150. Its NADAC has been published 193 times since Mar 29, 2017.
Strength
650 mg/1
Manufacturer
Chain Drug Marketing AssociationNDC
63868009150
Classification
Generic
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Last Updated
11/18/2020
Active Ingredients
ACETAMINOPHENApproval Type
Generic (ANDA)
FDA Application
ANDA076200On Market Since
4/30/2002
Price Statistics
The NADAC for QC ACETAMINOPHEN 8-HR 650 MG has been published 193 times since Mar 29, 2017, and over the history we have for it it has declined 3.1%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0606 per EA |
|---|---|
| All-time high | $0.0683 (Nov 13, 2019) |
| All-time low | $0.0572 (Oct 17, 2018) |
| Median price | $0.0618 |
| Average price | $0.0616 |
| Largest weekly change | +12.1% (Oct 23, 2019) |
| Weeks tracked | 193 |
| Tracking since | Mar 29, 2017 |
Generic Alternatives
The matcher finds 8 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 8 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of QC ACETAMINOPHEN 8-HR 650 MG?
The current National Average Drug Acquisition Cost (NADAC) for QC ACETAMINOPHEN 8-HR 650 MG, manufactured by Chain Drug Marketing Association, is $0.0606 per EA (NDC 63868009150), effective Dec 2, 2020.
How has the price of QC ACETAMINOPHEN 8-HR 650 MG changed over time?
Over the history we have for it, the NADAC for QC ACETAMINOPHEN 8-HR 650 MG has declined 3.1%. It has been tracked across 193 weekly CMS publications since Mar 29, 2017.
What are the highest and lowest recorded NADAC prices for QC ACETAMINOPHEN 8-HR 650 MG?
Since Mar 29, 2017, the NADAC for QC ACETAMINOPHEN 8-HR 650 MG has ranged from a low of $0.0572 (Oct 17, 2018) to a high of $0.0683 (Nov 13, 2019), with a median of $0.0618 per EA.
Are there cheaper alternatives to QC ACETAMINOPHEN 8-HR 650 MG?
Yes. 8 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, ARTHRITIS PAIN ER 650 MG CAPLT, is $0.0599 per EA — about 1% below QC ACETAMINOPHEN 8-HR 650 MG.
Who manufactures QC ACETAMINOPHEN 8-HR 650 MG?
QC ACETAMINOPHEN 8-HR 650 MG (NDC 63868009150) is labeled by Chain Drug Marketing Association, and CMS classifies it as a generic product.
Related Drugs
Same classification